Mizuho Maintains Buy on UDR, Lowers Price Target to $60
Mizuho analyst Haendel St. Juste maintains UDR (NYSE:UDR) with a Buy and lowers the price target from $61 to $60.
Earnings Scheduled For February 8, 2022
Companies Reporting Before The Bell
• Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.
Where UDR Stands With Analysts
Over the past 3 months, 5 analysts have published their opinion on UDR (NYSE:UDR) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Keybanc Maintains Overweight on UDR, Raises Price Target to $63
Keybanc maintains UDR (NYSE:UDR) with a Overweight and raises the price target from $61 to $63.
Expert Ratings For UDR
Within the last quarter, UDR (NYSE:UDR) has observed the following analyst ratings:
Keybanc Maintains Overweight on UDR, Raises Price Target to $61
Keybanc analyst Austin Wurschmidt maintains UDR (NYSE:UDR) with a Overweight and raises the price target from $58 to $61.
Morgan Stanley Downgrades UDR to Equal-Weight, Announces $59.5 Price Target
Morgan Stanley analyst Richard Hill downgrades UDR (NYSE:UDR) from Overweight to Equal-Weight and announces $59.5 price target.
UDR Sees Q4 2021 FFO $0.30-$0.32; Sees FY21 FFO $1.92-$1.94
Q4 2021
Outlook
Q3 2021
Actual
Updated
Full-Year 2021
Outlook
Prior
Full-Year 2021
Outlook
Change to
2021 Guidance,
at Midpoint
Net Income / (Loss) per
UDR Q3 FFO $0.46 Down From $0.50 YoY
UDR (NYSE:UDR) reported quarterly earnings of $0.46 per share. This is a 8 percent decrease over earnings of $0.50 per share from the same period last year.
Earnings Scheduled For October 26, 2021
Companies Reporting Before The Bell
• Veoneer (NYSE:VNE) is likely to report quarterly loss at $0.83 per share on revenue of $408.69 million.